查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1538445

腎上腺皮質荷爾蒙API 市場報告：2030 年趨勢、預測與競爭分析

Adrenocortical Hormone API Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

腎上腺皮質荷爾蒙API的趨勢與預測

預計 2024 年至 2030 年，全球腎上腺皮質荷爾蒙API 市場將以 5.9% 的複合年成長率成長。該市場的主要促進因素是對荷爾蒙補充療法的需求不斷成長以及腎上腺功能不全疾病盛行率的上升。全球腎上腺皮質荷爾蒙API 市場的未來充滿希望，注射、口服、外用和吸入市場充滿機會。

腎上腺皮質荷爾蒙API：按細分市場

該研究包括按類型、應用和地區分類的全球腎上腺皮質荷爾蒙API 的預測。

腎上腺皮質荷爾蒙API 市場洞察

Lucintel 預測潑尼松系列將出現最高的成長。

注射劑預計將在該市場中成長最快。

預計北美地區的成長最快。

常問問題

Q1.市場成長預測是多少：

A1. 2024年至2030年，全球腎上腺皮質荷爾蒙API市場預計將以5.9%的複合年成長率成長。

Q2. 影響市場成長的關鍵促進因素是：

A2. 該市場的主要驅動力是荷爾蒙補充療法的需求不斷成長以及腎上腺功能不全疾病的盛行率上升。

Q3.市場的主要細分市場是：

A3.腎上腺皮質荷爾蒙原料藥市場的未來充滿希望，注射劑、口服劑、外用劑和吸入劑市場都有機會。

Q4.市場的主要企業是：

A4. 主要腎上腺皮質荷爾蒙原料藥公司如下：

  • Pfizer CentreOne
  • EuroAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid Spa
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab

Q5.未來最大的細分市場是什麼？

A5.Lucintel預測潑尼松系列將經歷最高的成長。

Q6.未來五年預計哪些地區的市場成長最大？

A6 預計北美地區成長最快。

Q7. 可以客製化報告嗎？

A7.是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球腎上腺皮質荷爾蒙API 市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球腎上腺皮質荷爾蒙API市場趨勢（2018-2023）與預測（2024-2030）
  • 全球腎上腺皮質荷爾蒙API 市場：按類型
    • 潑尼松系列
    • 地塞米松系列
    • Betamethasone系列
    • Hydrocortisone系列
    • 其他
  • 全球腎上腺皮質荷爾蒙API 市場：依應用分類
    • 注射
    • 口服劑
    • 外用製劑
    • 吸入劑

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球腎上腺皮質荷爾蒙API 市場（按地區）
  • 北美腎上腺皮質荷爾蒙原料藥市場
  • 歐洲腎上腺皮質荷爾蒙原料藥市場
  • 亞太地區腎上腺皮質荷爾蒙原料藥市場
  • 其他地區腎上腺皮質荷爾蒙原料藥市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
  • 全球腎上腺皮質荷爾蒙原料藥市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球腎上腺皮質荷爾蒙原料藥市場產能擴張
    • 全球腎上腺皮質荷爾蒙API 市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • Pfizer CentreOne
  • EuroAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid Spa
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab
簡介目錄

Adrenocortical Hormone API Trends and Forecast

The future of the global adrenocortical hormone API market looks promising with opportunities in the injectable drug, oral drug, for external use drug, and inhalation drug markets. The global adrenocortical hormone API market is expected to grow with a CAGR of 5.9% from 2024 to 2030. The major drivers for this market are growing demand for hormonal replacement therapies and rising prevalence of adrenal insufficiency disorders.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Adrenocortical Hormone API by Segment

The study includes a forecast for the global adrenocortical hormone API by type, application, and region.

Adrenocortical Hormone API Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Prednisone Series
  • Dexamethasone Series
  • Betamethasone Series
  • Hydrocortisone Series
  • Others

Adrenocortical Hormone API Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Injectable Drug
  • Oral Drug
  • For External Use Drug
  • Inhalation Drug

Adrenocortical Hormone API Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Adrenocortical Hormone API Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies adrenocortical hormone API companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the adrenocortical hormone API companies profiled in this report include-

  • Pfizer CentreOne
  • EuroAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid Spa
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab

Adrenocortical Hormone API Market Insights

Lucintel forecasts that prednisone series is expected to witness the highest growth.

Within this market, injectable drug is expected to witness the highest growth.

North America is expected to witness the highest growth.

Features of the Global Adrenocortical Hormone API Market

Market Size Estimates: Adrenocortical hormone API market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Adrenocortical hormone API market size by type, application, and region in terms of value ($B).

Regional Analysis: Adrenocortical hormone API market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the adrenocortical hormone API market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the adrenocortical hormone API market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for adrenocortical hormone API market?

Answer: The global adrenocortical hormone API market is expected to grow with a CAGR of 5.9% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the adrenocortical hormone API market?

Answer: The major drivers for this market are growing demand for hormonal replacement therapies and rising prevalence of adrenal insufficiency disorders.

Q3. What are the major segments for adrenocortical hormone API market?

Answer: The future of the adrenocortical hormone API market looks promising with opportunities in the injectable drug, oral drug, for external use drug, and inhalation drug markets.

Q4. Who are the key adrenocortical hormone API market companies?

Answer: Some of the key adrenocortical hormone API companies are as follows:

  • Pfizer CentreOne
  • EuroAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid Spa
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab

Q5. Which adrenocortical hormone API market segment will be the largest in future?

Answer: Lucintel forecasts that prednisone series is expected to witness the highest growth.

Q6. In adrenocortical hormone API market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the adrenocortical hormone API market by type (prednisone series, dexamethasone series, betamethasone series, hydrocortisone series, and others), application (injectable drug, oral drug, for external use drug, and inhalation drug), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Adrenocortical Hormone API Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Adrenocortical Hormone API Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Adrenocortical Hormone API Market by Type
    • 3.3.1: Prednisone Series
    • 3.3.2: Dexamethasone Series
    • 3.3.3: Betamethasone Series
    • 3.3.4: Hydrocortisone Series
    • 3.3.5: Others
  • 3.4: Global Adrenocortical Hormone API Market by Application
    • 3.4.1: Injectable Drug
    • 3.4.2: Oral Drug
    • 3.4.3: For External Use Drug
    • 3.4.4: Inhalation Drug

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Adrenocortical Hormone API Market by Region
  • 4.2: North American Adrenocortical Hormone API Market
    • 4.2.1: North American Adrenocortical Hormone API Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
    • 4.2.2: North American Adrenocortical Hormone API Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
  • 4.3: European Adrenocortical Hormone API Market
    • 4.3.1: European Adrenocortical Hormone API Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
    • 4.3.2: European Adrenocortical Hormone API Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
  • 4.4: APAC Adrenocortical Hormone API Market
    • 4.4.1: APAC Adrenocortical Hormone API Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
    • 4.4.2: APAC Adrenocortical Hormone API Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
  • 4.5: ROW Adrenocortical Hormone API Market
    • 4.5.1: ROW Adrenocortical Hormone API Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
    • 4.5.2: ROW Adrenocortical Hormone API Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Adrenocortical Hormone API Market by Type
    • 6.1.2: Growth Opportunities for the Global Adrenocortical Hormone API Market by Application
    • 6.1.3: Growth Opportunities for the Global Adrenocortical Hormone API Market by Region
  • 6.2: Emerging Trends in the Global Adrenocortical Hormone API Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Adrenocortical Hormone API Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Adrenocortical Hormone API Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Pfizer CentreOne
  • 7.2: EuroAPI
  • 7.3: GlaxoSmithKline
  • 7.4: Teva Pharmaceutical Industries
  • 7.5: Hovione
  • 7.6: Axplora
  • 7.7: Steroid Spa
  • 7.8: Avik Pharmaceutical
  • 7.9: Anuh Pharma
  • 7.10: Symbiotec Pharmalab